2021 Anti-Parkinson Drugs Market Size, Growth, Drivers, Trends And Forecast
New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
The Anti-Parkinson Drugs Global Market Report 2021-30 by The
Business Research Company describes and explains the global anti-Parkinson
drugs market and covers 2015 to 2020, termed the historic period, and 2020 to
2025, termed the forecast period, along with further forecasts for the period
2025-2030. The report evaluates the market across each region and for the major
economies within each region.
The Anti-Parkinson Drugs Global Market Report 2021 covers anti-Parkinson
drugs market drivers, anti-Parkinson drugs market trends, anti-Parkinson drugs market
segments, anti-Parkinson drugs market growth rate, anti-Parkinson drugs market
major players, and anti-Parkinson drugs market size.
View Complete Report:
The anti-Parkinson drugs market report provides an in-depth analysis
of the impact of COVID-19 on the global anti-Parkinson drugs industry, along
with revised market numbers due to the effects of the coronavirus and the
expected anti-Parkinson drugs market growth numbers 2021-2030.
Anti-Parkinson Drugs Global Market Report 2021 is the most
comprehensive report available on this market and will help gain a truly global
perspective as it covers 60 geographies. The chapter on the impact of COVID-19
gives valuable insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The chapter also covers
markets which have been positively affected by the pandemic.
Request For The Sample
Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp
The global anti-Parkinson drugs market is expected to grow from $5.3
billion in 2020 to $5.55 billion in 2021 at a compound annual growth rate
(CAGR) of 4.7%. The market is expected to reach $7.78 billion in 2025 at a CAGR
of 9%.
The
report covers the anti-Parkinson drug market segments-
1) By Drugs Class: Levodopa/Carbidopa, Dopamine
Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors,
Catechol-O-Methyltransferase (COMT)-Inhibitors, Anticholinergics, Other Drugs.
2) By Route Of Administration: Oral, Injection, Transdermal.
3) By Distribution Channel: Hospital
Pharmacies, Retailer Pharmacies, Online Pharmacies.
About The Business Research Company:
The Business Research Company is a market research
and intelligence firm that excels in company, market, and consumer research. It
has over 200 research professionals at its offices in India, the UK and the US,
as well a network of trained researchers globally. It has specialist consultants
in a wide range of industries including manufacturing, healthcare, financial
services and technology. TBRC excels in company, market, and consumer research.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Email: info@tbrc.info
Comments
Post a Comment